Syndexa Pharmaceuticals Headquarters
Looking for information about Syndexa Pharmaceuticals Headquarters? The links below have collected all the necessary data.
Syndexa Pharmaceuticals - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/syndexa-pharmaceuticals
- Syndexa Pharmaceuticals Corp., a Watertown, MA-based biopharmaceutical company developing drugs to treat metabolic diseases. Founded by scientists from Harvard University, and led by President and CEO Teo Uysal, Syndexa is dedicated to the discovery and development of a new generation of small-molecule drugs targeting novel mechanisms for theFounded: 2005
Syndexa Pharmaceuticals Corp. - Company Profile - BCIQ
- https://www.biocentury.com/companies/Syndexa_Pharmaceuticals_Corp
- Syndexa Pharmaceuticals Corp. , Cambridge, Mass. Business: Endocrine/Metabolic, Cardiovascular Date completed: 1/5/12 Type: Venture financing Raised: $8.5 million Investor: MP Healthcare Venture Management Note: The financing is a series B-1 round.
Home - Syndax
- https://syndax.com/
- Syndax Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Business Update. 08.02.21. Syndax to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021. 06.28.21.
Syndexa Pharmaceuticals Corporation - WATERTOWN, MA ...
- https://www.dandb.com/businessdirectory/syndexapharmaceuticalscorporation-watertown-ma-24161462.html
- Syndexa Pharmaceuticals Corporation was founded in 2007, and is located at 480 Arsenal St in Watertown. Additional information is available at www.syndexa.com …Location: 480 Arsenal St, WATERTOWN, 02472-2891, MA
Syndexa Pharmaceuticals Corp - Company Profile and News ...
- https://www.bloomberg.com/profile/company/0116280D:US
- Company profile page for Syndexa Pharmaceuticals Corp including stock price, company news, press releases, executives, board members, and contact information
Contact Us - Syndax
- https://syndax.com/contact/
- New York Location 211 East 43rd Street #900 New York, NY 10017 646-690-7620 phone 212-867-5902 fax. GET DIRECTIONS
Syndax Pharmaceuticals - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/sndax-pharmaceuticals
- Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor,
Investors Syndax Pharmaceuticals, Inc.
- https://ir.syndax.com/
- Aug 02, 2021 · Investors. Syndax Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Through our pipeline agents, entinostat, a late stage, class 1 specific HDAC inhibitor and SNDX-6352, a phase 1 anti-CSF-1R monoclonal antibody, we are determined to realize ...
Syndexa Pharmaceuticals Corp. Targeting Metabolic Diseases ...
- https://www.fiercebiotech.com/biotech/syndexa-pharmaceuticals-corp-targeting-metabolic-diseases-raises-15m-series-b-financing
- May 30, 2008 · Syndexa Pharmaceuticals Corp. Targeting Metabolic Diseases, Raises $15M Series B Financing Cambridge, MA, May 30, 2008 - Syndexa Pharmaceuticals Corp., a biopharmaceutical company developing
Have you found Syndexa Pharmaceuticals Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.